Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trade Groups Dismiss Jarrow’s Criticism Of FDA’s Fabricant

This article was originally published in The Tan Sheet

Executive Summary

Dietary supplement industry trade groups disavow statements by Jarrow Formulas’ president that cast as industry consensus his criticism of Daniel Fabricant’s work as FDA’s top supplement program official.
Advertisement

Related Content

Natural Products Association Could Face Scrutiny Amid Legal Battles
NPA, Ex-CFO Weickert Exchange Unsavory Allegations In Legal Crossfire
NPA's Former CFO Alleges Improper Expenses By Fabricant, Religious And Gender Harassment
NPA's Former CFO Alleges Improper Expenses By Fabricant, Religious And Gender Harassment
Fabricant Ends Eventful Service In FDA Supplement Regulation To Head NPA
Fabricant Ends Eventful Service In FDA Supplement Regulation To Head NPA
Jarrow Formulas Founder Forms “More Creative” Supplement Trade Group
NDI Safety Data Guidance Sets Evidence Bar Too High, Attorney Says
Fabricant Will Helm FDA Dietary Supplement Office
Fabricant Will Helm FDA Dietary Supplement Office

Topics

Advertisement
UsernamePublicRestriction

Register

PS105280

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel